Entertainment
Disc Medicine Announces Successful End Of Phase 2 Meeting With FDA For Bitopertin In Erythropoietic Protoporphyria (EPP), Including Potential For Accelerated Approval
(MENAFN - GlobeNewsWire - Nasdaq) Alignment with the FDA across all proposed study parameters, providing a clear development path to registration Agreement on proposed primary endpoint of ...
By: menafn
- Nov 04 2024
- 0
- 0 Views
ONLY AVAILABLE IN PAID PLANS